Your browser doesn't support javascript.
loading
Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalities.
Gkika, E; Kostyszyn, D; Fechter, T; Moustakis, C; Ernst, F; Boda-Heggemann, J; Sarria, G; Dieckmann, K; Dobiasch, S; Duma, M N; Eberle, F; Kroeger, K; Häussler, B; Izaguirre, V; Jazmati, D; Lautenschläger, S; Lohaus, F; Mantel, F; Menzel, J; Pachmann, S; Pavic, M; Radlanski, K; Riesterer, O; Gerum, S; Röder, F; Willner, J; Barczyk, S; Imhoff, D; Blanck, O; Wittig, A; Guckenberger, M; Grosu, Anca-L; Brunner, T B.
Afiliación
  • Gkika E; Department of Radiation Oncology, University Medical Center Freiburg, Robert Koch Str 3, Freiburg, Germany. eleni.gkika@uniklinik-freiburg.de.
  • Kostyszyn D; Department of Radiation Oncology, University Medical Center Freiburg, Robert Koch Str 3, Freiburg, Germany.
  • Fechter T; Department of Radiation Oncology, University Medical Center Freiburg, Robert Koch Str 3, Freiburg, Germany.
  • Moustakis C; Department of Radiation Oncology, University Medical Center Muenster, Muenster, Germany.
  • Ernst F; Institute for Robotics and Cognitive Systems, University of Luebeck, Luebeck, Germany.
  • Boda-Heggemann J; Department of Radiation Oncology, Faculty of Medicine Mannheim, Department of Radiation Oncology, University of Heidelberg, Mannheim, Germany.
  • Sarria G; Department of Radiation Oncology, University Hospital Bonn, Bonn, Germany.
  • Dieckmann K; Department of Radiation Oncology, University Departments of the MedUni Vienna, Vienna General Hospital, Vienna, Austria.
  • Dobiasch S; Department of Radiation Oncology, Klinikum Rechts der Isar, TU Munich, Munich, Germany.
  • Duma MN; Department of Radiotherapy and Radiation Oncology, University Hospital Jena, Friedrich-Schiller University, Jena, Germany.
  • Eberle F; Department of Radiation Oncology, University Hospital Marburg, Marburg, Germany.
  • Kroeger K; Department of Radiation Oncology, University Medical Center Muenster, Muenster, Germany.
  • Häussler B; Radiation Oncology Dr. Häussler/Dr. Schorer, Munich, Germany.
  • Izaguirre V; Department of Radiation Oncology, University Hospital Halle, Halle, Germany.
  • Jazmati D; Proton Therapy Centre, University Hospital Essen, Essen, Germany.
  • Lautenschläger S; Department of Radiation Oncology, University Hospital, Marburg, Germany.
  • Lohaus F; Department of Radiation Oncology, University Hospital Dresden, Dresden, Germany.
  • Mantel F; Department of Radiation Oncology, University Hospital Würzburg, Würzburg, Germany.
  • Menzel J; Department of Radiation Oncology, University Hospital Hannover, Hannover, Germany.
  • Pachmann S; Department of Radiation Oncology, Weilheim Clinic, Weilheim, Germany.
  • Pavic M; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Radlanski K; Department of Radiation Oncology, Charite, University Hospital Berlin, Berlin, Germany.
  • Riesterer O; Centre for Radiation Oncology KSA-KSB, Kantonsspital Aarau, Aarau, Switzerland.
  • Gerum S; Department of Radiation Oncology, University Clinic, Paracelsus Medical University (PMU), Salzburg, Austria.
  • Röder F; Department of Radiation Oncology, University Clinic, Paracelsus Medical University (PMU), Salzburg, Austria.
  • Willner J; Department of Radiation Oncology, University Hospital Bayreuth, Bayreuth, Germany.
  • Barczyk S; Center for Radiation Oncology, Belegklinik am St. Agnes-Hospital, Bocholt, Germany.
  • Imhoff D; Department of Radiation Oncology, Saphir Radiosurgery, University Hospital Frankfurt, Frankfurt, Germany.
  • Blanck O; Saphir Radiosurgery, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Wittig A; Department of Radiotherapy and Radiation Oncology, University Hospital Jena, Friedrich-Schiller University, Jena, Germany.
  • Guckenberger M; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Grosu AL; Department of Radiation Oncology, University Medical Center Freiburg, Robert Koch Str 3, Freiburg, Germany.
  • Brunner TB; Department of Therapeutic Radiology and Oncology, Comprehensive Cancer Center, Medical University of Graz, Graz, Austria.
Strahlenther Onkol ; 199(11): 973-981, 2023 11.
Article en En | MEDLINE | ID: mdl-37268767
ABSTRACT

PURPOSE:

The aim of this study was to evaluate interobserver agreement (IOA) on target volume definition for pancreatic cancer (PACA) within the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Society of Radiation Oncology (DEGRO) and to identify the influence of imaging modalities on the definition of the target volumes.

METHODS:

Two cases of locally advanced PACA and one local recurrence were selected from a large SBRT database. Delineation was based on either a planning 4D CT with or without (w/wo) IV contrast, w/wo PET/CT, and w/wo diagnostic MRI. Novel compared to other studies, a combination of four metrics was used to integrate several aspects of target volume segmentation the Dice coefficient (DSC), the Hausdorff distance (HD), the probabilistic distance (PBD), and the volumetric similarity (VS).

RESULTS:

For all three GTVs, the median DSC was 0.75 (range 0.17-0.95), the median HD 15 (range 3.22-67.11) mm, the median PBD 0.33 (range 0.06-4.86), and the median VS was 0.88 (range 0.31-1). For ITVs and PTVs the results were similar. When comparing the imaging modalities for delineation, the best agreement for the GTV was achieved using PET/CT, and for the ITV and PTV using 4D PET/CT, in treatment position with abdominal compression.

CONCLUSION:

Overall, there was good GTV agreement (DSC). Combined metrics appeared to allow a more valid detection of interobserver variation. For SBRT, either 4D PET/CT or 3D PET/CT in treatment position with abdominal compression leads to better agreement and should be considered as a very useful imaging modality for the definition of treatment volumes in pancreatic SBRT. Contouring does not appear to be the weakest link in the treatment planning chain of SBRT for PACA.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Radiocirugia / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Strahlenther Onkol Asunto de la revista: NEOPLASIAS / RADIOTERAPIA Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Radiocirugia / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Strahlenther Onkol Asunto de la revista: NEOPLASIAS / RADIOTERAPIA Año: 2023 Tipo del documento: Article País de afiliación: Alemania